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Dual diagnosis has become a topic of interest in recent years. In South Africa individuals diagnosed with dual 
diagnosis are left without adequate services as a result of the separation of substance abuse and mental health 
treatment services. Through a phenomenological study the authors aimed to explore how adults diagnosed with 
both bipolar disorder and stimulant use disorder experienced treatment at treatment centres. Considered from a 
bio-psychosocial perspective, the findings give insight into service users’ living world with a dual diagnosis, their 
experiences, their unique needs for treatment and requirements to maintain abstinence. Recommendations for 
social work services at treatment centres are offered.   
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INTRODUCTION AND PROBLEM STATEMENT 
The United Nations Office on Drugs and Crime (UNODC) (2017:9) estimated that in the year 2015 
approximately 250 million adults were abusing illicit drugs globally. Illicit drugs are generally divided 
into four categories: opioids, stimulants, depressants and psychedelics (Nutt, 2012:38). The use of 
stimulant-type drugs is responsible for a significant portion of the global burden of disease ascribed to 
substance use, and the growing market for these types of drugs indicates higher rates of use (UNODC, 
2017:9). Stimulant drugs are defined as drugs that “increase respiration, heart rate, motor activity, and 
alertness” (Fisher & Harrison, 2013:21). Stimulant use disorder is defined by the American Psychiatric 
Association (2013b) as “[a] pattern of amphetamine-type substances, cocaine, or other stimulant use 
leading to clinically significant impairment or distress” (APA, 2013a:561). Even though most African 
countries have insufficient methods of tracking and reporting the prevalence of substance use disorders 
(SUD), the UNODC West African Commission on Drugs (WACD) (2014:40) reports an increase in the 
manufacture and seizure of methamphetamines – a stimulant drug. SUD is defined as “a cluster of 
cognitive, behavioural, and physiological symptoms indicating that the individual continues using the 
substance despite significant substance-related problems” (APA, 2013a:483).  
The Republic of South Africa (RSA) is a developing country consisting of nine provinces, home to a 
multicultural society, with the Gauteng province earning the highest per capita income in the country 
(RSA, 2018). Pretoria, located in the Gauteng province, is the administrative capital of the RSA and is 
the location of the research population reported on in this article (RSA, 2018). The South African 
Community Epidemiology Network on Drug Use (SACENDU) (2017:5) reported that between January 
and June of 2017 a total of 3 870 individuals were admitted to seventeen treatment centres in the 
Gauteng province, of whom 23% reported amphetamine-type stimulants as their primary or secondary 
drug of choice. The use of methcathinone (CAT), which is an amphetamine-based synthetic stimulant, 
is increasing in all provinces, but more so in the Gauteng province, where 9% of patients admitted to 
treatment reported CAT as their drug of choice (SACENDU, 2017:12). In addition, SACENDU 
(2017:12) reports that 39% of the 10 047 patients admitted to 80 treatment centres across South Africa 
during the first half of 2017 reported mental health problems upon admission.  
The National Institute on Drug Abuse in the United States of America (USA) (NIDA 2010:10) defines 
dual diagnosis (DD) as “[t]he occurrence of two disorders or illnesses in the same person, either at the 
same time (co-occurring comorbid conditions) or with a time difference between the initial occurrence 
of one and the initial occurrence of the other”. In the RSA mental disorders are diagnosed according to 
the Diagnostic and Statistical Manual of Mental Disorders (DSM), compiled by the APA. The APA 
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(2013b:4) explains that bipolar disorder (BD) was previously classified as a mood disorder, but became 
a separate category in the fifth edition of the DSM (DSM-5) as changes in energy levels and activity 
are as important as mood changes (APA, 2013a:810). Whenever the authors refer to BD in this article it 
is with reference to all types of BD as classified in the DSM-5 (APA, 2013a). 
A study conducted by Fabricius, Langa and Wilson (2007:7) aimed at establishing the prevalence of 
DD among individuals in a treatment centre in Johannesburg. It was found that 57% of the 419 patients 
had a DD. Swann (2010:278) maintains that patients diagnosed with BD are more inclined to use 
stimulant drugs as they want to achieve the level of mania they experience during a manic episode of 
BD. The higher prevalence of DD, however, is not limited to the RSA. Tiet and Mausbach (2007:513) 
explain that in the USA 60% of individuals who seek treatment for drug abuse are diagnosed with 
mental disorders, such as BD, and 56% of individuals seeking treatment for BD have a co-occurring 
substance use disorder.  
The presence of a DD complicates treatment in both disorders as individuals with a DD are less likely 
to comply with treatment and less likely to maintain abstinence in general, according to the National 
Alliance on Mental Illness (NAMI, 2013:1). Finding effective ways to treat these patients is made more 
difficult as there is a significant lack of information on the co-occurrence of BD and SUD, as well as 
the effects each has on the other (Swann, 2010:276). Information is limited as studies focusing on the 
treatment of BD usually exclude individuals with substance use disorders, thus little is known about the 
treatment of these patients (Weiss, Griffin, Jaffee, Bender, Graff, Gallop & Fitzmaurice, 2009:212). 
Fabricius et al. (2007:3) assert that it is no surprise that there is often no consensus concerning the 
treatment of DD, as there is no consensus on what causes it in the first place. 
The first author became aware of the complexity of treating DD patients while working at a long-term 
substance abuse treatment centre in Pretoria. It was noted that those patients with a DD were more 
prone to relapse, but very little information was available on treating these individuals more effectively. 
The DD of BD and stimulant substance abuse was chosen as a starting point for a dedicated study, as it 
was identified as a common co-occurrence among the individuals admitted to treatment. Even though 
most researchers as well as SACENDU (2017:27) and the Department of Social Development (DSD, 
2013a:3) acknowledge the high prevalence of DD in the RSA and calls for the development of 
treatment focused on this phenomenon, the authors were not able to identify research (EBSCOhost and 
Google Scholar) focused on intervention strategies. The authors agree with Matsea (2017) that the 
voice of service users should be heard to ensure that they are involved in the design of treatment 
programmes, as this has the potential to increase adherence to treatment, it generally improves the 
outcomes and prevents unnecessary expenditure. Therefore, the authors of this article aimed to explore 
how adult service users living with a DD of stimulant use disorder and BD experience treatment in in-
patient treatment centres for SUD. The authors aimed to answer the following research question: “How 
do adults living with stimulant use disorder and bipolar disorder experience treatment at in-patient 
treatment centres for SUD in the Gauteng province?”  
In order to contextualise DD all literature and research findings presented will be informed by a 
theoretical framework, viz. the bio-psychosocial perspective.  
BIO-PSYCHOSOCIAL PERSPECTIVE 
In 1977 George Engel introduced the bio-psychosocial (BPS) perspective to the medical field, urging 
medical professionals to consider the biological, psychological and social components influencing the 
lived experiences of individuals (Hatala, 2012:52). Routledge (2005:39) explains that the perspective 
focuses on three components of an individual: (1) bio, for biology, focuses on the genetic, biochemical 
and physical factors of a person; (2) psycho, for psychological, focuses on the developmental, 
psychological and psychopathological aspects of an individual; (3) social, focuses on family systems, 
diversity, culture, governments and social justice, which are all incorporated into the individual’s 
interpersonal relationships. The isolation of culture as a fourth component has, however, been 
207 
Social Work/Maatskaplike Werk 2019:55(2) 
suggested in recent years, as culture saturates the other three components (Hatala, 2012:58); this is 
particularly so in countries such as the RSA where traditional healthcare forms part of many cultures 
and is often consulted before conventional (Western) health care (Jack, Wagner, Petersen, Thorn, 
Newton, Stein, Kahn, Tollman & Hofman, 2014:4).  
In the RSA social workers are mainly responsible for the implementation of SUD treatment and usually 
focus on BPS components that ‘cause’ addiction and inform rehabilitation (Jack et al., 2014:4; Rassool, 
2011:94). In addition, the BPS perspective was adopted as the theoretical framework guiding this study 
as both BD and stimulant use disorder have shared biological, psychological and social components 
that influence the cause, progression and treatment of both disorders. The BPS perspective allowed the 
exploration of the multivariate nature of DD as expressed by participants themselves, for example, the 
effects that a physical component such as lifestyle have on the psychological well-being of individuals 
while in treatment. 
A brief overview of the causes, effects and treatment of both SUD and BD as separate disorders, as 
well as a DD, will be presented to shape the context of this study.  
SUBSTANCE USE DISORDERS: CAUSES, EFFECTS AND TREATMENT 
The causes of SUD are ascribed to various factors. The first is biological factors, such as genetics or 
neurochemicals, or a combination of them; the second, psychological factors such as turbulent home 
environments and undiagnosed mental health problems, and finally, social factors such as political 
turmoil, media and the school/work environment (Jack et al., 2014:3; Rassool, 2011:36).  
Increased levels of substance abuse inhibit educational and occupational progress as these are 
detrimental to the physical, cognitive and psychological health of individuals, and place stress on 
interpersonal relationships (Fisher & Harrison, 2013:171). In 2005 the costs related to the treatment of 
methamphetamine in the USA, a developed country, were US$23 billion (±R1.92 billion), including 
costs related to crime, environmental damage, lost productivity, infectious diseases, family disruptions, 
cognitive dysfunction and premature death (Brensilver, Heinzerling & Shoptaw, 2013:45). In the RSA, 
a developing country, the social and economic costs associated with SUDs was estimated at R105 
billion in 2013, placing an immense burden on healthcare and social welfare systems (DSD, 2013a:37). 
SUD is associated with worsened disease outcomes for various disorders, such as HIV and TB (DSD, 
2013a:37). 
Stimulants increase the activity of the central nervous system, which causes high levels of energy and 
mental functioning with a loss of appetite, followed by a phase of extreme fatigue, paranoia, anxiety 
and depression known as a “crash” (Rassool, 2011:83). The use of stimulant drugs is prevalent among 
individuals diagnosed with mental disorders and, in some cases, the diagnosis of BD can be overlooked 
as stimulants counter depressive mood cycles (Swann, 2010:278). Biological effects associated with 
stimulant drug abuse include nausea, insomnia, paranoia, anxiety, irregular heartbeat, excessive 
sweating, severe headaches, pressure on the chest, myocardial infarction, arrhythmias, cardiomyopathy, 
acute myocardial ischemia and sudden death (Nutt, 2012:118; Rassool, 2011:225). 
The treatment of SUD varies significantly, but most effective treatment interventions include and take 
into account the following aspects (Rassool, 2011:278): 
 Services should be available and accessible;
 Treatment should change according to the needs of an individual;
 The period spent in treatment should be adjusted and adequate for every individual;
 Both counselling and behavioural therapies should be included;
 Mental disorders and substance abuse should be diagnosed and treated concurrently;
 Involuntary treatment should not be deemed ineffective;
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 Detoxification should not be seen as part of treatment, but rather as the first step in preparing for
treatment;
 The diagnosis and treatment of infectious diseases should be part of treatment;
 Treatment should focus on the risk reduction of all spheres of functioning.
In the Framework for Social Welfare Services, the DSD (2013b:29) encourages social welfare 
practitioners to provide a continuum of services, informed by the individual needs of every service user 
and ultimately promoting the self-reliance and social functioning of these individuals.   
The following section will focus on the causes, effects, and treatment of bipolar disorder. 
BIPOLAR DISORDER: CAUSES, EFFECTS, AND TREATMENT  
The DSM-5 (APA, 2013a:810) points out that the focus of BD falls on changes in mood as well as 
changes in energy and activity involvement, and is therefore not deemed a pure mood disorder. In 
terms of a BD, moods are clustered into two groups, manic and depressive symptoms. Manic symptoms 
include euphoria, increased energy, increased drive to achieve goals and an increase in irritability, the 
need for sleep decreases, distractibility and self-confidence are heightened, and there is an increased 
involvement in activities despite damaging consequences (APA, 2013a:124). Depressive symptoms 
include a decrease in energy levels, an increase in feelings of hopelessness and/or worthlessness, low 
self-confidence, weight loss, sleep difficulty, an inability to concentrate and psychomotor retardation 
(APA, 2013a:125). The DSM-5 distinguishes between several types of bipolar and bipolar-related 
disorders which are diagnosed based on the severity of the manic and depressive symptoms and the 
period of time these symptoms remain present or active (APA, 2013a:123).  
The causes of BD are complex and can be ascribed to numerous factors such as genetics and 
neurochemicals, illicit drug use, the presence of other mental disorders and/or stressful life events 
(Miklowitz, 2010:41). The effects of BD are well documented and impact negatively on the physical, 
cognitive, emotional, financial, occupational and interrelational aspects of those affected 
(Archambeault, 2009:108). In recent years researchers have started to notice that ethnicity can play a 
role in the presentation of symptoms as well, after noticing higher levels of manic symptoms among 
black individuals in both the RSA and the United Kingdom (Grobler, 2012:164). In a study conducted 
by Lachman, Nessen, Hawkridge, and Emsley (2012) with 139 adolescents in a psychiatric hospital in 
the Western Cape Province, the use of methamphetamine was associated with high numbers of 
psychotic and mood disorders.  
The DSM-5 indicates that SUD among individuals living with BD is high and that more research 
focused on this phenomenon is necessary (APA, 2013a:144). Weiss et al. (2009:212) reiterate the lack 
of research on DD, more so on BD coupled with SUD, as most researchers deliberately exclude 
individuals abusing drugs from BD treatment studies. Swann (2010:278) warns that the DD of 
stimulant use disorder and BD are as difficult to diagnose as it is to treat, as stimulants can hide 
depressive moods or mimic manic symptoms; thus either diagnosis can be overlooked.  
Although the treatment of BD mostly focuses on pharmacotherapy, Archambeault (2009:107) 
encourages practitioners responsible for the treatment of BD to focus on all the bio-psychosocial 
aspects causing and maintaining any psychiatric diagnosis. Swann (2010:276) warns that SUD is the 
rule rather than the exception among individuals diagnosed with BD and is often detrimental to the 
effective treatment and recovery of individuals diagnosed with BD.  
DUAL DIAGNOSIS: CAUSES, EFFECTS AND TREATMENT 
The causes of DD are mainly attributed to four factors: (1) SUD allows individuals to feel that they are 
managing psychiatric symptoms; (2) SUD triggers the onset of psychiatric symptoms; (3) the same 
biological and social components predispose an individual to both; and (4) a high level of co-
occurrence is merely coincidental (Fabricius et al., 2007:2; NIDA, 2010:3). When considering these 
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explanations it is evident that identifying the causes of DD is complex, as it is the combination of the 
causes and effects of both disorders that leads to the development of the DD.  
There are similar effects in both stimulant use disorder and BD. These effects seem to escalate when 
grouped together, as chaotic use patterns are more prominent (Rassool, 2011:36). Some of the effects 
associated with DD include the following: shorter periods of recovery; more visits to emergency units 
and hospitalisation; higher rates of suicidal thoughts and attempts; frequent displays of impulsivity and 
violence; higher occupational impairment and school drop-out rates; regular non-adherence to 
treatment; mixed mood states; higher levels of anxiety disorders; diminished quality of life; and poor 
treatment outcomes associated with HIV and TB (Lachman et al., 2012; Rassool, 2011:22).  
Effective treatment outcomes greatly depend on early detection as, with time, symptoms become so 
intertwined that determining where one disorder ends and the other begins becomes impossible 
(Salloum, Pani & Cooke, 2010:354). Early detection is unfortunately not the norm, as individuals 
presenting with psychotic symptoms are generally not accepted into SUD treatment programmes in the 
RSA until symptoms have been treated (Lachman et al., 2012). Grobler (2012:6) acknowledges that as 
research on mental health care in the RSA is lacking, it is difficult to encourage people to seek 
treatment and provide accurate information. Even if individuals seek treatment, the primary health care 
system is already flooded and resources limited, thus making an accurate diagnosis and effective 
treatment very unlikely. The treatment gap is a major concern as most researchers agree that both 
disorders should be treated simultaneously and that the severity of both disorders should determine the 
time that treatment should continue (Fabricius et al., 2007:4; Rassool, 2011:218).  
Pasche and Myers (2012:340) highlight that the historic separation of two sectors – the DSD heading 
substance abuse treatment and the Department of Health (DoH) providing mental health treatment – 
leaves both sectors poorly equipped to deal with DD effectively and concurrently. Despite the fact that 
the DSD (2013a:3) acknowledges the lack of available DD services in the RSA, available services 
remain inaccessible and unaffordable to the majority of the population (Lachman et al., 2012; Pasche & 
Myers, 2012:339).  
Treatment specific to the RSA context is complex as most research focuses on the treatment or course 
of either SUD (Pasche & Myers, 2012:340) or BD (Grobler, 2012:6). Completed research that focused 
mostly on DD concentrated on determining its prevalence, rather than establishing specific treatment 
experiences of patients (Fabricius et al., 2007:14). Hence, the literature underscored the rationale for 
the study, namely to explore how adult service users living with a DD of stimulant use disorder and BD 
experience treatment within in-patient treatment centres for SUD. 
An overview of the research methods will be offered, followed by a discussion on the findings of the 
study, presented as themes and sub-themes, as well as conclusions and recommendations highlighting 
the most important aspects of this phenomenon as it relates to treatment. 
RESEARCH METHODS 
Rooted in phenomenology as research paradigm (Nieuwenhuis, 2016:60-62), a qualitative research 
approach enabled the authors to explore how people diagnosed with both bipolar disorder and stimulant 
use disorder experience treatment at in-patient treatment centres in the Gauteng province (Isaacs, 
2014:318). The study had an exploratory purpose to gain as much understanding of the participants’ 
personal experiences, especially as the study was the first of its kind in the RSA. The 
phenomenological research design, specifically the transcendental sub-design, was used as the authors 
aimed to describe authentically the lived experiences of adults living with a DD while in treatment 
without detailed interpretations by the authors (Creswell, 2013:80).   
The research population was comprised of adults who had been admitted to three treatment centres in 
Pretoria (Gauteng province), who had been diagnosed with both BD and stimulant use disorder. All 
patients diagnosed with BD were included in the study, irrespective of the subtype of the bipolar 
diagnosis. Purposive sampling was used in a three-phase process to identify the research sample. In 
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phase one purposive sampling was used to select three treatment centres in Pretoria where potential 
participants could be recruited. After permission was obtained from the treatment centres, inclusion 
criteria were provided to a social worker at each treatment centre, which aided in the identification of 
possible participants. Phase two of the sampling process, which was also purposive sampling, revolved 
around the identification of participants based on specific inclusion criteria, namely:  
 Individuals who were older than 18 years;
 Individuals who had a stimulant drug addiction, which includes cocaine, CAT, khat or meth;
 Individuals who were not in the detoxification phase of treatment;
 Individuals living with the DD of stimulant use disorder and BD, which was confirmed by a
medical practitioner or psychiatrist;
 Individuals could be either male or female;
 Individuals could be part of any religious and/or ethnic group;
 Individuals who could converse in Afrikaans or English.
In the third phase of the sampling process, all possible participants who met the inclusion criteria were 
approached by the social worker of the treatment centre and could volunteer to participate in the study. 
Even though the authors hoped to include a larger sample, four participants eventually participated. 
Nonetheless, Creswell (2013:78) states that sample sizes for phenomenological studies are often small 
(e.g. three participants). 
The data-collection method used was a semi-structured one-on-one interview that was guided by an 
interview schedule. One interview, lasting up to 90 minutes, was conducted with each participant at his 
or her treatment site. The particular data-collection method was beneficial as it allowed enough 
freedom to explore the personal experiences of each participant (Isaacs, 2014:321).  
All data collected were analysed through the process of thematic analysis (Clarke, Braun & Hayfield, 
2015:223). Even though thematic analysis is not commonly associated with a phenomenological 
research design, Clarke and Braun (2013:120) explain that in recent years this form of analysis has 
received recognition along methodologies such as interpretative phenomenological analysis (IPA). 
Thematic analysis is also not confined to fixed theoretical frameworks and is seen as a basic method 
that is appropriate for any sample size (Clarke & Braun, 2013:120).  
A number of strategies were adopted to ensure the trustworthiness of the study. Auditability was 
ensured by keeping field notes and a journal, consulting with a co-researcher and developing 
transcripts, which could be reviewed (Lietz & Zayas, 2010:195; Padgett, 2017:220). Credibility, how 
accurately data are presented, was maintained by discussing all themes and sub-themes with the co-
author, as well as by performing member checking with one of the research participants (Lietz & 
Zayas, 2010:192; Padgett, 2017:219). Confirmability was achieved as most research findings could be 
confirmed by comparing research findings with literature (Lietz & Zayas, 2010:197). Transferability is 
possible when research findings could contribute to future research, theories, or practice. 
Transferability was ensured in this study by declaring all research processes, which could enable 
replication of the study (Lietz & Zayas, 2010:195).  
Ensuring confidentiality, obtaining written informed consent from all participants and no harm were 
some of the ethical considerations that were adhered to during the study (Rubin & Babbie, 2017:85-90). 
The research study also received ethical clearance from the Research Ethics Committee of the 
university (Ref no.: GW20160523HS). 
FINDINGS 
Table 1 contains the biographical details of the participants. 
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TABLE 1 
PROFILE OF PARTICIPANTS 
Curre
nt age 
Age when 
stimulant 
abuse started 
Age when 
bipolar disorder 
was diagnosed 
Gender 
Number 
of 
children 
Race 
Level of 
education 
Participant 1 
(PAR01) 
37 16 28 Male 0 White 
Honours 
degree 
Participant 2 
(PAR02) 
21 19 21 Male 0 White Grade 12 
Participant 3 
(PAR03) 
24 16 19 Male 0 White Grade 12 
Participant 4 
(PAR04) 
28 14 25 Female 1 White Grade 12 
Merikangas and Peters (2010:55) state that BD affects men and women equally, but women over-
represent the population in psychiatric treatment centres. In addition to this NIDA (2010:9), in the 
USA, reports that in terms of DD men seem to access rehabilitation programmes more frequently, 
while women are more inclined to access psychiatric treatment. 
All the participants had previously been admitted to SUD treatment programmes, three participants also 
mentioned prior admission to psychiatric treatment centres, a finding that correlates with Lachman et 
al. (2012), who reported re-admission rates of 41% to psychiatric treatment programmes among South 
African youths. It is noteworthy that all participants started using stimulants before they were 
diagnosed with BD. 
The study’s findings will be presented in the format of themes and sub-themes (Figure 1). 
FIGURE 1 
OVERVIEW OF THEMES AND SUB-THEMES OF STUDY 
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Theme 1: Me, Myself and I 
The consideration of all BPS aspects influencing the development, course, and progression of both 
disorders should be considered throughout the treatment process to promote recovery.   
Sub-theme 1.1: Where I’m at 
Prior to treatment, participants used stimulants as a means of managing rapid mood changes. As all 
participants received pharmacological treatment, it would be assumed that their moods were stable. 
However, regardless of pharmacological treatment focused on biological aspects, participants still 
experienced unstable mood patterns on a psychological level that triggered cravings for drugs on a 
physical level. 
“… my mood … in the space of one day goes … up-and-down, up-and-down, up-and-down. 
You can’t ask me how did I feel today. Because you’d have to ask me that like every hour.” 
(PAR02) 
“A lot of the times, I’m down and it makes me wish that I could get back to drugs to get like 
that quick fix to get happy and high again.” (PAR03) 
Participants explained how their mood would fluctuate multiple times during one day; however, it is 
during depressive cycles that they craved stimulants most, as they longed to experience manic 
symptoms. As participants did not have access to substances of abuse during treatment, they resorted to 
other means of managing moods, as discussed in the following section.  
Sub-theme 1.2: My quick fix 
Generally, individuals display behaviour or use products to alleviate emotional discomfort and manage 
moods. As seen in the previous section most participants reverted to stimulants to manage moods; 
however, while in the treatment they resorted to other ‘quick fixes’.  
“I need something to be happy, all the time. Whether it is drugs, or watching a movie, or, 
something needs to be there to make me happy.” (PAR02) 
“If I’m extremely, extremely depressed and I can’t do anything… Go to the bathroom. Slit. 
Come out. Then I’m happy. Healed.” (PAR02) 
“Uhm psychologically this is tough hey. Like in the other rehabs, you can call your parents … 
you can get like tuck (tuck shop) every single day … you eat chocolate every day so you can 
like feed some kind of … a need or a lack or whatever, you can fill yourself with, with, with 
nonsense.” (PAR01) 
“I just wanted to go and lie down and just escape the world, you know.” (PAR01) 
Medication, food, sugar, contact with significant others, coffee, cigarettes, and self-mutilation are some 
of the ‘fixes’ that were mentioned by participants which offered psychological relief. As these products 
and behaviours can become habitual, referred to as cross-addictions, they carry their own set of risks, 
indicating that the root of the problem is still not being treated despite pharmacotherapy.   
As a result of the continued mood instability, most participants considered discontinuation of treatment 
at some point. Reasons for remaining in treatment were mostly rooted in the sense of responsibility that 
the participants felt.  
Sub-theme 1.3: It’s my responsibility 
Most participants believed that by remaining in treatment they took responsibility for various BPS 
factors.  
“Uhm … I think that for my relationship with my parents a long-term programme is the only 
option I have. So, me not being here isn’t actually an option.”(PAR01) 
213 
Social Work/Maatskaplike Werk 2019:55(2) 
“So inside I’m super sad, I’m destroying myself, I’m depressed, I’m thinking about suicide, 
but on the outside, I’m putting up this face and trying to work the programme, and trying to 
advance in the programme, you know.”(PAR02) 
Participants remained in treatment in an attempt to convince family members that they are committed, 
or because they are at an age or time in their life when they believe it is necessary to take responsibility 
for their actions. Other participants, however, remained in treatment to “get it over and done with” 
regardless of the psychological discomfort they experience during treatment. Interestingly, 
responsibility was expressed in terms of SUD, but not in terms of BD, a component that will be 
addressed in sub-theme 2.3.  
The following theme will report on aspects of treatment which participants found beneficial. 
Theme 2: In Abundance, Please! 
In this theme, the need for physical and psychological aspects of treatment will be indicated.   
Sub-theme 2.1: Counselling 
The following statements indicate that counselling is one aspect of treatment that all participants 
esteemed:   
“I need to speak about what’s going on with me ... I don’t know how to process the hurt.” 
(PAR01) 
“I live from one counselling session to the next.” (PAR01) 
“I struggle to uhm handle my own like emotions and things that I’m not in control of and they 
don’t teach you how to control that in the beginning.” (PAR03) 
Two participants stated that they live from one counselling session to the next, as they need counselling 
to process what is going on in their mind. Counselling was seen as the most beneficial component in 
managing emotions and stress, and participants indicated that they would not recover without it. Most 
participants expressed a need for more counselling and most called for at least two sessions per week. 
One participant who received counselling twice a week, one session with a case manager and a second 
with a clinical psychologist, was satisfied, validating the need expressed by other participants.   
Even though it appears as if counselling would be sufficient for recovery, participants valued a focus on 
physical aspects of treatment as well.   
Sub-theme 2.2: Body 
Concerning the physical components of treatment, participants said the following: 
“... there is ‘gymming’ equipment … that’s how I handle emotion. Because emotion handles 
me.” (PAR02) 
“... exercise is good especially when you are having a difficult time…” (PAR03) 
Participants considered exercise as a valuable component of treatment in terms of managing mood and 
emotions. Other participants mentioned that healthy lifestyle factors, such as eating habits and sleep 
patterns, held great benefits and aided recovery. Education in terms of the role of a healthy lifestyle 
after treatment was, however, a need for one participant. The subsequent section will focus on other 
areas where education should take place as part of treatment. 
Sub-theme 2.3: Education 
Participants mentioned a need for education focused on a broad spectrum of topics: 
“… knowledge of your addiction … and to learn to cope and a healthy lifestyle outside… 
what they do here is very good… there just needs to be more." (PAR02) 
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“The drug use and the bipolar… I know they might be similar but … I would like to 
differentiate between the two and get to know myself better as well.” (PAR03) 
Topics of interest included education on BD and addiction as diseases, developing coping skills, 
understanding how a healthy lifestyle promotes recovery and how BD and stimulant use influence each 
other. Most participants felt education should take place one-on-one with a professional as well as in 
groups consisting of individuals who share the same diagnosis.  
It was thought-provoking to see that all participants saw education focused on both SUD and BD as a 
means of promoting recovery and verifying their BD diagnosis, as seen below: 
“... like a lot of uhm psychiatrist just label uhm a lot of drug addicts as bipolar so that’s why 
I’d like to learn more about it, and you can maybe differentiate between the two.” (PAR03) 
“I don’t think it is really treated here… we get sent to the psychiatrist but … basically just to 
get me on pills it’s not actually to help me manage… I haven’t gained any knowledge of my 
BD.” (PAR02) 
Another participant explained that anyone going to a psychiatrist while intoxicated or withdrawing 
from stimulants would be diagnosed with BD. Yet another participant explained that substance use 
suppresses emotions and, when the use of drugs is discontinued, years of emotions rush out and create 
unstable moods that can be mistaken for BD. From these statements, it appears as if most participants 
firstly, view BD as a label or misdiagnosis, and secondly, deems knowledge on the causes, effects and 
management of their diagnosis as more beneficial than pharmacological treatment. In light of sub-
theme 1.3, it appears that the participants found it difficult to take responsibility for managing a 
disorder when they question the accuracy of the diagnosis from the onset. 
The following statement represents participants’ belief that education should be extended to significant 
others as well: 
“The people that are close to us, uhm should also be taught on uhm how to handle cravings 
… how to handle … us as, as addicts … because we are manipulative as well and they should 
be able to see past that.” (PAR03) 
With this quotation, it is evident that participants desire exposure to and the inclusion of other 
individuals in treatment.  
Theme 3: All for One and One for All 
All for one and one for all is a phrase used to indicate (1) that a group can support an individual, if the 
individual contributes to the group, and (2) that when individuals work together they can achieve both 
the group’s goals and their personal goals. The interplay between shared experiences, while still 
maintaining individualised treatment, is explained in the next two sub-themes.  
Sub-theme 3.1: Shared experiences 
Group therapy and support groups are common in the treatment of both SUD and mental disorders, for 
example, Alcoholics Anonymous (AA), and Narcotics Anonymous (NA) groups. The following 
statements indicate why participants found groups beneficial:  
“… in group therapy sessions … you process so much there and you just connect with the 
other people…and you’re like ‘oh my goodness I can relate to that’… it’s not just me…” 
(PAR01) 
“…the people that are here… that have been clean for long, and to see how they live and how 
their lives are coming right. It shows that there is hope.” (PAR04) 
“…we should invite people from the outside to join our groups or we should travel to the 
outside groups, which are already set out there and hear stories from different people … what 
got them through it.” (PAR03) 
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It appears that groups can validate and normalise experiences for participants. One participant 
explained that having contact with other people who have recovered and are able to live ‘normal’ lives 
are a source of hope. In addition to hope, knowledge was an additional benefit derived from interaction 
with individuals who have maintained abstinence. Confrontation by counsellors and other individuals 
in recovery has long been a part of SUD treatment and was a beneficial and valued component of 
treatment for participants when appropriately utilised.  
Sub-theme 3.2: Personal experiences 
Exposure to individuals who share similar experiences appears to promote recovery; however, when 
experiences are generalised, individual needs are neglected and recovery demoted, as seen in the 
following quotations:  
“… they must help guide you through that certain situation … because they tend to generalise 
it… instead of helping you through specific problems…” (PAR03) 
“… for them, it was like a communication thing, they were like "aw, no we understand the 
way you feel if you have issues" and I was like oh well that’s one way of looking at it. I was 
just doing it because it makes me feel better. Point. [explaining response from staff to self-
harm].” (PAR02)  
During interviews, two participants shared that they self-mutilated during treatment. The first 
participant saw self-mutilation as a means of communication, to show the treatment centre that he did 
not agree with certain aspects of treatment. The second participant experienced emotional relief when 
he self-mutilated; however, the treatment centre saw it as a way of communicating, instead of teaching 
him more effective coping mechanisms. It is evident that consideration of individual treatment needs 
should be taken into account as failing to do so could jeopardise long-term recovery. 
Theme 4: In the Long Run 
Essentially the objective of treatment is to ensure that an individual is able to achieve and maintain the 
highest possible personal level of functioning and not merely abstinence from substances of abuse. It 
appears that the most detrimental factor to long-term recovery is opposing treatment goals, as seen in 
the following quotes:  
“I said to her specifically … I won’t take anything that will make me pick up weight because 
I’ve got very bad body dysmorphic disorder... it’s a trigger for me you know; when I used 
meth [methamphetamine] I was so lean it was the most beautiful feeling.” (PAR01) 
“...they have more addressed the issue of the substance abuse than the bipolar. No matter if, 
even if I come to them with my emotional problems, they rather just address religion and 
substance abuse.” (PAR03) 
In this case it appears as if the goal of the psychiatrist was to prescribe the most effective medication to 
address the biological component of BD. The goal of the participants was, however, to maintain a 
certain image that was being threatened by the prescribed medication, regardless of the fact that this 
concern was mentioned, and ignored. It can be assumed that this participant is at a high risk of non-
adherence and relapse, as the negative effects associated with medication triggers discomfort, a 
discomfort that can be addressed by a stimulant.   
Other participants stated that they believe that they were in the wrong ‘type’ of treatment centre 
because the goals they had for treatment and the focus of the treatment centre were different. The 
following comments expand on the participants’ views: 
“…spiritually, they do a good job here…That’s why there is lacking in the other things.” 
(PAR02) 
“…I need to get affirmation…I seek that stuff…” (PAR01) 
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“…I think there should be more…confrontation group [sic], where we call people out on their 
bad behaviour, their addictive behaviour.” (PAR03) 
The quotations above highlight some opposing treatment goals, such as spirituality, confrontation and 
rewards.  
DISCUSSION 
Generally, the initial focus of treatment falls on addressing biological components, for example, the 
prescription of medication to stabilise mood cycles in BD (Archambeault, 2009:108), and the use of 
medication to manage withdrawal symptoms associated with stimulant drug abuse (Rassool, 2011:94). 
Despite pharmacological intervention, most participants reported unstable moods that appeared to 
cause psychological discomfort and triggered cravings for stimulants. On the basis of similar 
observations, authors such as Fisher and Harrison (2013:151) described medication as a merely 
complementary therapy. Unfortunately, as researchers still debate the causes of DD, there are few 
studies focused on its treatment, apart from pharmacological interventions (Weiss, Griffin, Kolodziej, 
Greenfield, Najavits, Daley, Doreau & Hennen, 2007:100). As non-adherence to BD medication is 
estimated at 70%, there is a dire need for alternative forms of treatment (Miklowitz, 2010:45). 
As participants did not have access to stimulant drugs during treatment, they turned to other substances 
and behaviours, termed cross-addictions, in an attempt to manage psychological stress, a phenomenon 
that is common among individuals in treatment for SUD (Fisher & Harrison, 2013:40). Common cross-
addictions include food, sweets, exercise, caffeine, sex, gambling, nicotine, relationships and self-
mutilation (Evren & Evren, 2005:19; Fisher & Harrison, 2013:290). As cross-addiction plays a 
functional role, it indicates that treatment needs are not being met and that certain BPS factors are 
neglected (Engel, 1981:103). Empowering individuals with skills to manage psychological stressors is 
crucial as cross-addiction poses a risk to recovery; for example, Frye and Perugi (2010:33) report that 
nicotine inhibits the effectiveness of bipolar treatment and aggravates symptoms.  
In addition to cross-addiction, certain internal motivators such as a sense of responsibility encouraged 
participants to remain in treatment. Taking responsibility for recovery appeared to be an individual 
process, not deliberate or guided, motivated by personal drive or the anticipation of gaining something. 
One participant perceived ‘taking responsibility’ for recovery as an opportunity to restore interpersonal 
relationships, where another was so focused on getting through treatment that he neglected to disclose 
and address psychological discomfort, thus not taking responsibility for recovery. ‘Taking 
responsibility’ should be a topic of interest during treatment and reintegration; however, treatment 
goals should be realistic and take place in an appropriate timeframe to promote recovery (Miklowitz, 
2010:27). Social workers should ensure that service users take responsibility for their treatment and 
cooperate with the treatment plan, which includes disclosure of underlying disparities that caused stress 
(Engel, 1981:102). It is noteworthy that responsibility was only expressed concerning SUD treatment 
as, so we believe, all participants questioned their BD diagnosis, describing it as a label or 
misdiagnosis. Swann (2010:278) acknowledges that misdiagnosis is common as stimulant drugs mimic 
symptoms of hypomania; however, NIDA (2010:7) emphasises the need for an accurate diagnosis, as 
treatment goals and ultimately treatment outcomes will depend on the diagnosis made. 
All participants considered counselling as the most beneficial part of treatment, as it was the most 
effective way of relieving psychological stressors and managing unstable moods, despite medication. In 
support of this view, research findings indicate that a safe environment where individuals can share 
perceptions and experiences has been found to be beneficial in the treatment of both SUD (Fisher & 
Harrison, 2013:57) and BD (Archambeault, 2009:118). Focusing on various BPS components of 
treatment is necessary, as focus on only one indicates possible neglect of another (Hatala, 2012:52). 
Most participants expressed a need for more counselling, while one participant, receiving counselling 
from different professionals, expressed satisfaction with counselling. Services provided by different 
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disciplines seem to be effective and is encouraged by Rassool (2011:228), who describes addiction and 
mental disorders as a multidisciplinary problem and encourages professionals to work together.   
Pharmacotherapy in the treatment of both BD and SUD aids in the management of symptoms because 
of their effect on neurotransmitters (Miklowitz, 2010:41; Nutt, 2012:69). Zastrow (2012:359) explains 
that, in addition to other physiological and psychological effects, physical exercise influences these 
same neurotransmitters. In support of these views, participants appeared to value the psychological 
benefits associated with exercise more than its physiological benefits. Bordbar and Faridhosseini 
(2012:324) hold that knowledge regarding how lifestyle influences psychological symptoms and the 
effectiveness of medication, as well as knowledge regarding side effects of medication, needs to form 
part of treatment. Interestingly, some participants expressed a need for education in this regard.   
Psycho-education that includes emotional, behavioural and cognitive therapies can ensure that 
individuals develop coping skills to manage psychological and social stressors as well as identifying 
triggers for both disorders (Miklowitz, 2010:27; Weiss et al., 2007:101). Acceptance of a diagnosis is 
important, as individuals are more likely to access services if they believe they need it and if they 
believe the service provider can fulfil these needs (Engel, 1981:102). Acceptance and utilisation of 
treatment lead to lower relapse rates, which ensures better health outcomes for individuals as well as 
lowered psychological and financial strain on families and healthcare systems (Fisher & Harrison, 
2013:56). Some participants mentioned that psycho-education should include family members, a need 
supported by researchers, who indicate that lower relapse rates occur when patients and families 
received information on both disorders and treatment options, while fostering realistic expectations 
regarding recovery and treatment (Miklowitz, 2010:27; Rassool, 2011:226). 
Social workers and other members of the multidisciplinary team should consider the effect of culture, 
because high instances of social exclusion and political turmoil, as is the case in the RSA and most 
developing countries, generally leads to higher rates of mental health problems and SUD (Lachman et 
al., 2012). Additionally, treatment of mental health is often insufficient in multicultural countries, as 
Western culture primarily informs treatment methods, which are not always appropriate in multicultural 
settings (Allott, cited in Archambeault, 2009:27). In fact, the Framework for Social Welfare Services 
(DSD, 2013b:29) calls on service providers to render services on a continuum ranging from prevention 
to aftercare and reintegration services and discourages over-reliance  on treatment along.  
Traditional treatment of both mental disorders and SUD includes group therapy, as it creates a platform 
where individuals can share experiences, achieve the common goal of recovery, and build supportive 
relationships while gaining knowledge and hope (Fisher & Harrison, 2013:144). Fisher and Harrison 
(2013:151) warn that the needs of individuals should be considered and guide treatment, as not 
everyone will derive the same benefits from groups. The idea that individuals should receive treatment 
based on their individual needs is the very essence of the BPS perspective (Engel, 1981:102). 
Therefore, adapting programmes to the multivariate nature of SUD and BD is essential to promote 
effective treatment (Merikangas & Peters, 2010:56).   
In terms of the treatment of DD, most researchers agree that both disorders need to be treated 
simultaneously as the neglect of one disorder can cause relapse in both disorders (Camacho & Frye, 
2010:190). In the USA Weiss (2004) implemented outpatient groups focused on the DD of BD and 
general SUD when they discovered that separate treatment groups often had opposing goals, triggering 
a relapse. For example, should an NA group discourage the use of any medication and a BD support 
group is uninformed regarding the behaviours indicating SUD, the relapse of either disorder could be 
overlooked thus leaving service users (i.e., participants) without appropriate support to maintain the 
best possible quality of life given their DD (Miklowitz, 2010:301). Salloum et al. (2010:354) explain 
that treating an acute disorder is normally successful and achieved easily, but the focus shifts to 
maintaining long-term stability when multiple chronic disorders such as BD and SUD need to be 
treated simultaneously. As recovery is a lifelong process, it is important to ensure that service users and 
their families are included in goal setting and that they understand and approve the treatment plan, as 
218 
Social Work/Maatskaplike Werk 2019:55(2) 
this promotes treatment adherence and long-term recovery in both disorders (Fisher & Harrison, 
2013:151; Miklowitz, 2010:27). Discomfort caused by opposing treatment goals was evident during 
interviews with participants and was caused by various aspects, such as disagreements in terms of 
medication, religion, a lack of rewards and the inappropriate use of confrontation in treatment. In an 
attempt to deliver adequate services, social workers are urged to understand the BPS aspects 
determining the onset, course and progression of both disorders to ensure effective treatment and allow 
sufficient time for recovery and reintegration (Fisher & Harrison, 2013:49).  
All the findings reached in this study should ultimately inform policy development. Archambeault 
(2009:118) urges social workers to accept the influence they have on policies that guide the 
development of intervention protocols. Policies should ensure that treatment respects multicultural 
societies such as the RSA, where appropriate interventions should especially infiltrate the primary 
health care system (Jack et al., 2014:7). Jack et al. (2014:2) acknowledge that, unfortunately, 
discussions regarding the implementation of the national health insurance in the RSA do not focus on 
mental health care services as part of the primary health care system at this stage, although a lack of 
trained staff is another pitfall facing the RSA.   
The article aimed to describe how adults living with the DD of stimulant use disorder and BD 
experience treatment. The authors believe this is the first study in the RSA that aimed to explore how 
treatment is experienced. The research sample, however, does not represent the experiences of 
individuals in public or psychiatric treatment programmes, or those diagnosed with different dual 
diagnoses. Another limitation includes the absence of all ethnic groups in the RSA, as all the 
participants who volunteered their participation in this study were white.  
The goal of phenomenological studies is not generalisability but rather understanding the meanings 
assigned to experiences. The goal of the phenomenological approach coupled with steps taken to ensure 
the trustworthiness of the study has the potential not only to have an impact on individual lives in the 
RSA, but also on those in other developing countries, especially those in Southern Africa. 
CONCLUSIONS 
The nature of the study allowed for the gathering of rich data focusing on a diverse range of aspects 
moulding the experiences of participants. The authors believe that the conclusions and 
recommendations outlined below highlight the most important aspects of this phenomenon. 
In general, DD has become a topic of interest in recent years and research focused on various types of 
DD is necessary for the establishment of effective treatment. A lack of epidemiological data on the 
prevalence of both stimulant use disorder and BD globally, and in the RSA specifically, means the 
prevalence and actual impact of this DD on individuals and society is unknown. In addition, the 
development of effective treatment will be inhibited as well, effectively delaying recovery and 
escalating negative effects, supporting the call of various authors for more research. 
Similarities regarding the effects of stimulant use and BD overlap on various levels. Biologically, the 
same neurotransmitters are involved in the course and progression of both stimulant use disorder and 
BD. Compared to individuals with no diagnosis, those diagnosed with SUD or BD has been found to 
have poor psychological health in general. The financial and emotional strain placed on social systems, 
such as families and governments, are more severe when BD or stimulant use is diagnosed. As 
numerous risk factors, causes and effects associated with the development and course of BD and 
stimulant use overlap, it can be assumed that individuals will be prone to develop both disorders. In the 
absence of a DD and the holistic treatment thereof, the poor outcome of treatment is inevitable.  
Concerning the treatment, pharmaceuticals are common in the treatment of biological components 
associated with BD and managing withdrawal associated with stimulants. Treatment of psychological 
components seems more complex as stimulants are described as more psychologically addictive than 
physically addictive, whereas individuals diagnosed with BD need to become comfortable with the idea 
219 
Social Work/Maatskaplike Werk 2019:55(2) 
of living without the presence or anticipation of manic episodes. In general, treatment outcomes are 
more favourable when social systems are included in treatment and support recovery.  
It is clear that pharmacological treatment and a formal diagnosis was not sufficient in managing 
symptoms or encouraging individuals to take ownership of their recovery. Rather, psycho-education 
and counselling were seen as the most beneficial aspects addressing the psychological needs of 
individuals living with this specific DD. Education in terms of lifestyle, treatment options and 
outcomes of treatment should be addressed. The individual needs of patients should be respected and 
guide treatment on a continuous basis and all physical, cognitive and interpersonal factors that can 
promote recovery should be included; for example, exercise, group therapy and religion/spirituality. 
Treatment groups seem to have the most profound impact and act as a source of education and 
motivation while providing hope for full recovery while addressing the lack of available social workers 
and other service providers in the RSA. 
Social workers, service users and family members should understand and acknowledge the risks and 
effects of secondary problems as well; for example, nicotine can aid in managing depressive moods; 
however, individuals using nicotine have been found to be more resistant to BD medication, making 
mood relapse more probable. More in-depth and treatment-specific education for social workers in 
DSD and other service providers in DoH in the RSA is, however, a crucial step in developing and 
treating DD effectively.   
The inclusion of professionals and policy developers is important, as the divide between psychiatric 
services headed by the DoH, and SUD services headed by the DSD has caused a treatment gap to 
develop where those most in need of services are lost. Echoing this recommendation, SACENDU 
(2017:27) expresses a need for lobbying for resources directed to understanding and addressing this 
growing phenomenon. 
Future research should repeat this study in private and government-based treatment centres across the 
RSA. Results from different studies should also be compared to determine the most prominent 
treatment needs. Treatment programmes should be developed, implemented and evaluated to determine 
if treatment needs have been met.  
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